UDOW vs. CURE
Compare and contrast key facts about ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE).
UDOW and CURE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. UDOW is a passively managed fund by ProShares that tracks the performance of the Dow Jones Industrial Average (300%). It was launched on Feb 9, 2010. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. Both UDOW and CURE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: UDOW or CURE.
Performance
UDOW vs. CURE - Performance Comparison
Returns By Period
In the year-to-date period, UDOW achieves a 38.42% return, which is significantly higher than CURE's 0.81% return. Over the past 10 years, UDOW has outperformed CURE with an annualized return of 20.23%, while CURE has yielded a comparatively lower 13.42% annualized return.
UDOW
38.42%
1.33%
20.51%
71.88%
12.49%
20.23%
CURE
0.81%
-21.53%
-14.14%
20.85%
10.76%
13.42%
Key characteristics
UDOW | CURE | |
---|---|---|
Sharpe Ratio | 2.18 | 0.67 |
Sortino Ratio | 2.77 | 1.08 |
Omega Ratio | 1.36 | 1.14 |
Calmar Ratio | 2.35 | 0.53 |
Martin Ratio | 11.57 | 2.55 |
Ulcer Index | 6.17% | 8.46% |
Daily Std Dev | 32.82% | 32.07% |
Max Drawdown | -80.29% | -69.19% |
Current Drawdown | -5.70% | -28.66% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
UDOW vs. CURE - Expense Ratio Comparison
UDOW has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.
Correlation
The correlation between UDOW and CURE is 0.72, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
UDOW vs. CURE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
UDOW vs. CURE - Dividend Comparison
UDOW's dividend yield for the trailing twelve months is around 0.88%, less than CURE's 1.51% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ProShares UltraPro Dow30 | 0.88% | 0.95% | 0.83% | 0.26% | 0.19% | 0.61% | 0.73% | 0.13% | 0.67% | 0.21% | 0.46% | 0.35% |
Direxion Daily Healthcare Bull 3x Shares | 1.51% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% | 0.00% | 1.24% |
Drawdowns
UDOW vs. CURE - Drawdown Comparison
The maximum UDOW drawdown since its inception was -80.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UDOW and CURE. For additional features, visit the drawdowns tool.
Volatility
UDOW vs. CURE - Volatility Comparison
ProShares UltraPro Dow30 (UDOW) has a higher volatility of 13.34% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 10.51%. This indicates that UDOW's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.